FDA Revokes Emergency Use Authorization Of Covid Drug Ineffective Against New Variants

Evusheld does not neutralize several omicron subvariants including BQ.1, BQ.1.1, BF.7, BF.11, BA.5.2.6, BA.4.6, BA.2.75.2, XBB and XBB.1.5, the FDA said in a press release.
Read Original Article: FDA Revokes Emergency Use Authorization Of Covid Drug Ineffective Against New Variants »